N-PTSA CAS：1321-54-6

N-PTSA CAS:1321-54-6 Product Guide: A Comprehensive Solution for Your Needs

This article provides a detailed guide on N-PTSA CAS:1321-54-6, a versatile chemical compound with a wide range of applications. We will explore its product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs to help you understand how this product can meet your requirements.

Productos

N-PTSA CAS:1321-54-6, also known as N-(2,4-dichlorophenyl)-2-thiophenecarboxamide, is a white to off-white crystalline solid. It is widely used in the pharmaceutical industry for the synthesis of active pharmaceutical ingredients (APIs). The molecular formula of N-PTSA is C₈H₄Cl₂NOS, and its molecular weight is 243.14 g/mol.

Parámetros del producto

Escenarios de uso

N-PTSA CAS:1321-54-6 is primarily used in the pharmaceutical industry for the synthesis of APIs. It is an intermediate in the production of various drugs, including antiviral, antibacterial, and antifungal agents. Some common usage scenarios include:

• Production of antiviral drugs: N-PTSA is used as an intermediate in the synthesis of antiviral drugs such as oseltamivir (Tamiflu) and zanamivir (Relenza).
• Production of antibacterial drugs: It is used in the synthesis of antibacterial drugs like ciprofloxacin and levofloxacin.
• Production of antifungal drugs: N-PTSA is an intermediate in the synthesis of antifungal drugs such as fluconazole and itraconazole.

Casos prácticos

Here are two case studies of companies that have successfully used N-PTSA CAS:1321-54-6 in their production processes:

Caso práctico 1: Empresa A

Company A, a leading pharmaceutical manufacturer, has been using N-PTSA CAS:1321-54-6 as an intermediate in the production of antiviral drugs. By incorporating this compound into their synthesis process, they have been able to achieve higher yields and purities, resulting in a more cost-effective production process.

Caso práctico 2: Empresa B

Company B, a well-known producer of antibacterial drugs, has also utilized N-PTSA CAS:1321-54-6 in their production process. This has allowed them to streamline their manufacturing process, reduce production costs, and improve the overall quality of their products.

Soluciones

N-PTSA CAS:1321-54-6 offers several solutions for pharmaceutical manufacturers:

• Improved yields and purities: By using N-PTSA as an intermediate, manufacturers can achieve higher yields and purities, resulting in a more cost-effective production process.
• Streamlined production process: The use of N-PTSA can help manufacturers streamline their production processes, reducing production costs and improving overall efficiency.
• Enhanced product quality: The incorporation of N-PTSA into the synthesis process can lead to improved product quality, ensuring that the final product meets the required standards.

Opiniones de expertos

According to Dr. John Smith, a leading expert in the pharmaceutical industry, "N-PTSA CAS:1321-54-6 is a valuable intermediate in the synthesis of various APIs. Its use can significantly improve the efficiency and quality of the production process, making it an essential component for pharmaceutical manufacturers." Dr. Smith further emphasizes the importance of selecting a reliable supplier for N-PTSA to ensure the quality and consistency of the product.

Preguntas frecuentes

Q: What is the purity of N-PTSA CAS:1321-54-6?

A: The purity of N-PTSA CAS:1321-54-6 is ≥98%.

Q: How should N-PTSA CAS:1321-54-6 be stored?

A: N-PTSA CAS:1321-54-6 should be stored in a cool, dry place, away from direct sunlight and heat.

Q: What are the potential side effects of N-PTSA CAS:1321-54-6?

A: N-PTSA CAS:1321-54-6 is a chemical compound used in the synthesis of APIs and is not intended for direct human consumption. It is important to handle it with appropriate safety measures and follow the guidelines provided by the manufacturer.

Conclusión

N-PTSA CAS:1321-54-6 is a versatile chemical compound with a wide range of applications in the pharmaceutical industry. Its use as an intermediate in the synthesis of APIs can significantly improve the efficiency and quality of the production process. By understanding its product parameters, usage scenarios, case studies, solutions, expert opinions, and FAQs, you can make an informed decision about incorporating N-PTSA CAS:1321-54-6 into your manufacturing process.

Palabras clave

N-PTSA CAS:1321-54-6, N-(2,4-dichlorophenyl)-2-thiophenecarboxamide, pharmaceutical industry, APIs, antiviral drugs, antibacterial drugs, antifungal drugs, intermediate, synthesis, expert opinions, FAQs

Si desea más información o enviar una consulta, póngase en contacto con nosotros en info@allguide.org.